Sign inJoin waitlistJoin the waitlist

NG

Natalie Galanina

Associate Professor of Medicine, Division of Hematology/Oncology · UPMC Medical Education

Credentials: · · · · · ·

History

UPMC Medical Education
Present

Hematology and Medical Oncology
2012–2015
Yale University
2009–2012
Doctor of Medicine
2005–2009

Research

Real-world data from a molecular tumor board demonstrates improved outcomes with a precision N-of-One strategy
Nature Communications · 2020 · 245 citations
Clonal evolution underlying leukemia progression and Richter transformation in patients with ibrutinib-relapsed CLL
Blood Advances · 2017 · 118 citations
Successful Treatment of HIV-Associated Kaposi Sarcoma with Immune Checkpoint Blockade
Cancer Immunology Research · 2018 · First of 5 authors · Corresponding · 89 citations

CN
Chadi Nabhan
6 papers
Razelle Kurzrock
5 papers
Sonali Smith
4 papers
AG
Aaron Goodman
3 papers
AP
Adam Petrich
3 papers
Girish Venkataraman
3 papers
JA
Jacob Adashek
2 papers · 2 as a resident
Jeremy Segal
2 papers
Madina Sukhanova
2 papers
Wendy Stock
2 papers
Andrew Evens
1 paper
Andrew Sharabi
1 paper

Clinical trials

Golcadomide and Nivolumab in Patients With Non-Hodgkin Lymphoma With Refractory Disease After Chimeric Antigen T-cell Therapy
Principal investigator · Withdrawn · Phase 1, Phase 2
University of Pittsburgh
2025–2028
An Open Label Navigational Investigation of Molecular Profile-Related Evidence Determining Individualized Cancer Therapy for Patients With Incurable Hematologic Malignancies (I-PREDICT Heme)
Principal investigator · Terminated
University of California, San Diego
2019–2021
Pacritinib in Relapsed/Refractory T-cell Lymphoproliferative Neoplasms
Site PI · Recruiting · Phase 2
University of Michigan Rogel Cancer Center
2023–2028